Evommune, Inc.
EVMN
DELAYED 1 MONTH
7 insider filings · Latest: Jun 2, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 2, 2026 | Jun 4 12:03 AM | David E CohenDirector | Sale | 6,056 | $20.33 | $123.1K | 17,609(D) | View → |
| Jun 1, 2026 | Jun 4 12:02 AM | Jeegar Pravinkumar PatelChief Scientific Officer | Sale | 16,687 | $22.74 | $379.5K | 46,403(D) | View → |
| Jun 1, 2026 | Jun 4 12:02 AM | Luis C. PenaDirector, President & CEO | Sale | 16,787 | $22.74 | $381.7K | 637,896(D) | View → |
| May 28, 2026 | Jun 2 12:00 AM | Gregory S. MossChief Business & Legal Officer | Sale | 14,223 | $22.83 | $324.7K | 60,835(D) | View → |
| May 28, 2026 | Jun 1 11:59 PM | Kyle CarverChief Financial Officer | Sale | 18,175 | $22.84 | $415.1K | 59,335(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 2, 2026 | Jun 4 12:04 AM | Benjamin F Mcgraw IIIDirector | Grant/Award | 15,673 | $19.82 | 15,673(D) | View → |
| Jun 2, 2026 | Jun 4 12:03 AM | Arthur S KirschDirector | Grant/Award | 15,673 | $19.82 | 15,673(D) | View → |
| Jun 2, 2026 | Jun 4 12:03 AM | David E CohenDirector | Grant/Award | 15,673 | $19.82 | 15,673(D) | View → |
| Jun 1, 2026 | Jun 4 12:02 AM | Jeegar Pravinkumar PatelChief Scientific Officer | Option Exercise | 13,512 | $3.84 | 29,330(D) | View → |
| May 28, 2026 | Jun 2 12:00 AM | Gregory S. MossChief Business & Legal Officer | Option Exercise | 14,223 | $1.71 | 47,845(D) | View → |
| May 28, 2026 | Jun 1 11:59 PM | Kyle CarverChief Financial Officer | Option Exercise | 15,000 | $2.99 | 96,731(D) | View → |